Bank of America
RUBY

Bank of America’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bank of America’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,286
Closed -$3.38K – 8576
2022
Q4 		$3.38K Buy
19,286
+16,079
+501% +$4.39K ﹤0.01% 7132
2022
Q3 		$1K Sell
3,207
-208,344
-98% -$156K ﹤0.01% 7738
2022
Q2 		$180K Buy
211,551
+79,754
+61% +$134K ﹤0.01% 6165
2022
Q1 		$726K Buy
131,797
+69,073
+110% +$439K ﹤0.01% 5521
2021
Q4 		$607K Buy
62,724
+21,268
+51% +$295K ﹤0.01% 5691
2021
Q3 		$741K Buy
41,456
+25,685
+163% +$559K ﹤0.01% 5331
2021
Q2 		$384K Sell
15,771
-1,587
-9% -$39.7K ﹤0.01% 5626
2021
Q1 		$460K Sell
17,358
-8,513
-33% -$124K ﹤0.01% 5436
2020
Q4 		$197K Buy
25,871
+3,468
+15% +$20.6K ﹤0.01% 5608
2020
Q3 		$112K Buy
22,403
+4,678
+26% +$24.8K ﹤0.01% 5632
2020
Q2 		$106K Buy
17,725
+3,272
+23% +$19.3K ﹤0.01% 5638
2020
Q1 		$65K Sell
14,453
-2,871
-17% -$21.3K ﹤0.01% 5762
2019
Q4 		$164K Sell
17,324
-9,352
-35% -$90.5K ﹤0.01% 5743
2019
Q3 		$209K Buy
26,676
+4,333
+19% +$50.5K ﹤0.01% 5644
2019
Q2 		$351K Buy
22,343
+15,240
+215% +$246K ﹤0.01% 5302
2019
Q1 		$128K Sell
7,103
-3,945
-36% -$60.5K ﹤0.01% 5741
2018
Q4 		$178K Buy
11,048
+9,473
+601% +$173K ﹤0.01% 5594
2018
Q3 		$38K Buy
+1,575
New +$36K ﹤0.01% 6323

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Bank of America's RUBY Position: Q1 2023 in Review

Bank of America sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 19,286 shares — an estimated $3.38K sold.

Bank of America first reported a position in RUBY in Q3 2018 and held it in 18 quarters. The position peaked at $741K in Q3 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Bank of America reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 19,286 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $3.38K.
  • Bank of America first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 18 quarters.
  • Bank of America's Rubius Therapeutics, Inc position peaked at $741K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.